Literature DB >> 17044017

TANGO is a tumor suppressor of malignant melanoma.

Stephanie Arndt1, Anja K Bosserhoff.   

Abstract

The TANGO gene was originally identified as a new family member of the melanoma inhibitory activity gene family. The gene codes for a 14 kDa protein of so far unknown function. In our study we revealed that TANGO was downregulated or lost in 9 melanoma cell lines when compared to normal melanocytes and in most of the 8 tumor samples analyzed. The losses were associated with advanced stage of the disease. These results were confirmed in situ by immunohistochemistry on 10 paraffin-embedded sections of human malignant melanoma primary tumors and melanoma skin metastases. A small reduction of TANGO was also seen in different benign and atypical nevi when compared to normal skin. For functional analysis of TANGO we evaluated TANGO re-expressing melanoma cell clones and antisense TANGO cell clones with a complete loss of TANGO. Functional assays with TANGO transfected or treated cell lines revealed that TANGO expression reduces motility, whereas reduction of TANGO enhances migration. Our studies, therefore, indicate that reduction of TANGO expression contributes to tumor progression. These results taken together provide the first indications for a tumor suppressor role of TANGO gene in human malignant melanoma. Copyright 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17044017     DOI: 10.1002/ijc.22242

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  17 in total

1.  Biomarkers: the useful and the not so useful--an assessment of molecular prognostic markers for cutaneous melanoma.

Authors:  Bonnie E Gould Rothberg; David L Rimm
Journal:  J Invest Dermatol       Date:  2010-06-17       Impact factor: 8.551

2.  Association study between polymorphisms in MIA3, SELE, SMAD3 and CETP genes and coronary artery disease in an Iranian population.

Authors:  Sima Rayat; Nasim Ramezanidoraki; Nima Kazemi; Mohammad H Modarressi; Masoumeh Falah; Safoura Zardadi; Saeid Morovvati
Journal:  BMC Cardiovasc Disord       Date:  2022-06-30       Impact factor: 2.174

3.  Identification of oral squamous cell carcinoma markers MUC2 and SPRR1B downstream of TANGO.

Authors:  Tomonori Sasahira; Miyako Kurihara-Shimomura; Hiroyuki Shimomura; Anja Katrin Bosserhoff; Tadaaki Kirita
Journal:  J Cancer Res Clin Oncol       Date:  2021-02-23       Impact factor: 4.553

4.  Genetic variants identified in a European genome-wide association study that were found to predict incident coronary heart disease in the atherosclerosis risk in communities study.

Authors:  Jan Bressler; Aaron R Folsom; David J Couper; Kelly A Volcik; Eric Boerwinkle
Journal:  Am J Epidemiol       Date:  2009-12-02       Impact factor: 4.897

Review 5.  Update of molecular pathobiology in oral cancer: a review.

Authors:  Tomonori Sasahira; Tadaaki Kirita; Hiroki Kuniyasu
Journal:  Int J Clin Oncol       Date:  2014-03-25       Impact factor: 3.402

6.  Global defects in collagen secretion in a Mia3/TANGO1 knockout mouse.

Authors:  Deanna G Wilson; Khanhky Phamluong; Li Li; Mei Sun; Tim C Cao; Peter S Liu; Zora Modrusan; Wendy N Sandoval; Linda Rangell; Richard A D Carano; Andrew S Peterson; Mark J Solloway
Journal:  J Cell Biol       Date:  2011-05-23       Impact factor: 10.539

7.  Molecular signature of cell cycle exit induced in human T lymphoblasts by IL-2 withdrawal.

Authors:  Magdalena Chechlinska; Jan Konrad Siwicki; Monika Gos; Malgorzata Oczko-Wojciechowska; Michal Jarzab; Aleksandra Pfeifer; Barbara Jarzab; Jan Steffen
Journal:  BMC Genomics       Date:  2009-06-08       Impact factor: 3.969

8.  Modelling gene expression profiles related to prostate tumor progression using binary states.

Authors:  Emmanuel Martinez; Victor Trevino
Journal:  Theor Biol Med Model       Date:  2013-05-31       Impact factor: 2.432

9.  A GNAS mutation found in pancreatic intraductal papillary mucinous neoplasms induces drastic alterations of gene expression profiles with upregulation of mucin genes.

Authors:  Hirotake Komatsu; Etsuko Tanji; Naoaki Sakata; Takeshi Aoki; Fuyuhiko Motoi; Takeshi Naitoh; Yu Katayose; Shinichi Egawa; Michiaki Unno; Toru Furukawa
Journal:  PLoS One       Date:  2014-02-03       Impact factor: 3.240

10.  Topoisomerase 2 Alpha Cooperates with Androgen Receptor to Contribute to Prostate Cancer Progression.

Authors:  J L Schaefer-Klein; Stephen J Murphy; Sarah H Johnson; George Vasmatzis; Irina V Kovtun
Journal:  PLoS One       Date:  2015-11-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.